How to ensure a needs-driven and community-centred vaccination strategy for COVID-19 in Africa.
How to ensure a needs-driven and community-centred vaccination strategy for COVID-19 in Africa.
复制标题
DOI:
10.1136/bmjgh-2021-005306
复制
发表时间:
2021-03
影响因子:
8.1
通讯作者:
Okonta C
中科院分区:
文献类型:
--
作者:
Boum Ii Y;Ouattara A;Torreele E;Okonta C
Despite pledges from world leaders for equitable access and fair allocation of COVID-19 vaccines globally, vaccine nationalism and hoarding, in particular by wealthy countries, have left Africa largely side-lined in the race to start vaccinating the most vulnerable and effectively curb the pandemic (figure 1). The African Union and Africa centre for disease control and prevention (CDC) recently announced that they were able to secure 670 million doses, 1 yet delivery times are unclear. South Africa, by far the hardest hit country on the continent, just received a first shipment of a last-minute procured 1.5 million doses. Unfortunetely they had to give the Astra Zeneca doses because of the high proportion of new variants on which this vaccine is performing poorly. 2 Nevertheless, the public discourse from health experts and politicians including in Africa continues to envision vaccination of two-thirds of the population in order to control COVID-19, as also outlined in a recent Lancet editorial. 3 It assumes that the strategy of rushing towards mass-vaccination with the first available vaccines, as pursued by several wealthy countries, is both realistic and desirable everywhere. Such uniform thinking, including the focus on securing large numbers of doses, overlooks that distinct country realities may require different COVID-19 responses, including vaccination strategies, and that local stakeholders and communities have a central role in designing and implementing successful public health interventions.While COVID-19 vaccines undoubtedly will have a critical role, they are no silver bullets. As we know from experience working in West and Central Africa, including responding to Ebola epidemics, there is a huge gap between having a vaccine authorised and deploying vaccination as an effective public health intervention. We already know that vaccine
登录
查看更多内容
DOI:
10.1016/s1473-3099(20)30700-3
发表时间:
2021-01
期刊:
The Lancet. Infectious diseases
影响因子:
--
作者:
Weiss DJ;Bertozzi-Villa A;Rumisha SF;Amratia P;Arambepola R;Battle KE;Cameron E;Chestnutt E;Gibson HS;Harris J;Keddie S;Millar JJ;Rozier J;Symons TL;Vargas-Ruiz C;Hay SI;Smith DL;Alonso PL;Noor AM;Bhatt S;Gething PW
通讯作者:
Gething PW
影响因子:
8.1
作者:
Murphy A;Mbau L;McKee M;Hanson K;Torreele E
通讯作者:
Torreele E
影响因子:
56.3
作者:
Moore, Kerryn A.;Simpson, Julie A.;McGready, Rose
通讯作者:
McGready, Rose
DOI:
10.1057/s41301-020-00261-1
发表时间:
2020
期刊:
Development (Society for International Development)
影响因子:
--
作者:
Torreele E
通讯作者:
Torreele E